Stumbled across an update on the 008 trial.........
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381039
Key points:
- last patient enrolment expected 25/3/22 (just over 5 weeks away). I like the sound of that given a 56 day primary endpoint and topline soon after.
- addition of NSW centre. Novatrials if anyone is interested...https://www.novatrials.com.au/current-trials#currently-enrolling
Oh, and while on the ANZCTR site, a recent update on MPS1.........
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=379536
Of note is expected recruitment of last patient on 30/6/22 (this too sounds good to me given we are currently sitting at only 3 of the 10 recruited)
Stumbled across an update on the 008...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $68.29M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.5¢ | $189.9K | 940.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 436602 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 332703 | 5 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |